Welcome to The Walnut!
The Walnut is the official newsletter for PCS Ottawa, currently published approximately four times a year.
Every issue includes:
- Recaps of PCSO meetings and events
- Announcements about upcoming meetings and events
- Health and nutrition news
- Survivor stories
- Updates on new, innovative prostate and recurrent cancer treatment
- Research and diagnostics
- Photos, funny moments…and anything else we can come up with!
Get your copy of The Walnut
The Walnut is available on our website as a free downloadable PDF file.
Contact the editor
What a year it’s been! But we made it.
And our organization thrived, grew and changed.
The Walnut: Recent issues
The best thing that might be said about 2020 is that it’s over. Vaccines for a virus we had barely even heard of a year ago are now approved and being administered to Canadians.
In this issue, we will bring you the latest information about the leading vaccines and how they might affect you, whether you are a current or a former prostate cancer patient. There’s a lot to absorb, and I hope I have separated the wheat from the chaff.
The Walnut does not regularly publish in the summer and the pandemic caused disruption on PCCNO’s regular meetings and AGM. In the meantime there was a change at the national level with the Prostate Cancer Canada Network’s amalgamation with the Canadian Cancer Society. In this issue, you will receive important information about how this change affects us at the local level.
In recent weeks, our world has changed dramatically, and in some ways, possibly forever, due to the spread of the COVID-19 virus. This is especially problematic for people living with serious health issues and/or compromised immune systems, and also for people over the age of 60. In this issue we will update you on what the Canadian Cancer Society says about cancer and COVID-19 and how PCCN Ottawa is adapting.
We will also take a look at a range of treatment options and strategies for living with and managing prostate cancer, including coping with stress, eating right and learning how exercise can give you a much-needed boost, both mentally and physically. Additionally, we have information about new ADT online classes, plus a personal story from a local, longtime cancer survivor and PCCN Ottawa board member.
Screening and early detection: why are men reluctant?
Screening is the most common method for early detection of prostate cancer. We all know that if you catch cancer early you are more likely to survive.
Yet not all men are proactive in making sure to seek early detection through screening.
In this issue, we explore some of the factors, such as lack of awareness, beliefs and attitudes that can discourage men’s involvement in prostate cancer screening and early detection activities. We also explore the pros and cons of screening and look at some best practices.
From a partner’s perspective: living with prostate cancer
In this issue, we explore the concerns and needs of partners of survivors. Three overarching themes are discussed: 1) coping with life in the face of cancer, 2) encountering difficult emotions related to a partner’s illness, and 3) learning to live with relationship changes.
We look at these at various stages of the prostate cancer “journey”: diagnosis and treatment, and what that experience is like for couples, what they find as helpful, harmful, and surprising throughout the experience, what couples and families need through and following treatment, and how men and women think and respond differently to intimacy and relationship challenges that occur as a result of prostate cancer diagnosis and treatment.
Get involved with PCS Ottawa.
Prostate Cancer Support Ottawa is 100% volunteer-run.
Help promote prostate cancer awareness
Prostate Cancer Support Ottawa provides speakers, professionally designed display units and accompanying literature for use at health fairs, sporting events, in shopping malls…any place people gather.
Contact us for more information on hosting an awareness event!
You can help protect men and their families from prostate cancer.